C16ORF52 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.076780E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.041560E-01 |
Normal-vs-Stage2 |
3.309400E-01 |
Normal-vs-Stage3 |
1.376730E-04 |
Normal-vs-Stage4 |
2.26479999999585E-05 |
Stage1-vs-Stage2 |
8.973400E-01 |
Stage1-vs-Stage3 |
3.958700E-03 |
Stage1-vs-Stage4 |
1.481490E-03 |
Stage2-vs-Stage3 |
9.344000E-02 |
Stage2-vs-Stage4 |
7.549900E-02 |
Stage3-vs-Stage4 |
8.341000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.240500E-03 |
Normal-vs-AfricanAmerican |
1.279650E-03 |
Normal-vs-Asian |
5.249000E-01 |
Caucasian-vs-AfricanAmerican |
2.496400E-01 |
Caucasian-vs-Asian |
7.356200E-01 |
AfricanAmerican-vs-Asian |
3.840600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.407900E-04 |
Normal-vs-Female |
4.013600E-02 |
Male-vs-Female |
1.625410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.159170E-04 |
Normal-vs-Age(41-60Yrs) |
4.850400E-02 |
Normal-vs-Age(61-80Yrs) |
5.375800E-04 |
Normal-vs-Age(81-100Yrs) |
5.689600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.981300E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.401600E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.989990E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.189160E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.145600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.847000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.767800E-01 |
Normal-vs-Grade 2 |
4.318200E-01 |
Normal-vs-Grade 3 |
1.85681000000049E-05 |
Normal-vs-Grade 4 |
5.43530000007841E-07 |
Grade 1-vs-Grade 2 |
4.244200E-01 |
Grade 1-vs-Grade 3 |
3.257200E-03 |
Grade 1-vs-Grade 4 |
1.856090E-03 |
Grade 2-vs-Grade 3 |
3.422800E-04 |
Grade 2-vs-Grade 4 |
1.9699300000009E-05 |
Grade 3-vs-Grade 4 |
4.096100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.019600E-01 |
Normal-vs-ccB subtype |
5.71139999999692E-05 |
ccA subtype-vs-ccB subtype |
4.35690000000211E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.538700E-03 |
Normal-vs-N1 |
2.37280000003892E-06 |
N0-vs-N1 |
2.820500E-03 |
|
|